Key points are not available for this paper at this time.
A selenophene substituted sematic liquid crystalline donor is developed to achieve outstanding PCEs for binary ASM-OSCs (15.8%) and thick-film ASM-OSCs (14.3%).
Xu et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: